Physician profile
William Harris
NPI 1821162207
$995.64
in general payments reported to CMS, 2019-2025
10 companies · $94.25 in 2025
The $94.25 reported for 2025 was less than what a typical Geriatric Medicine (Family Medicine) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $85.00 · 2021: $12.08 · 2022: $179 · 2023: $314 · 2024: $193 · 2025: $94.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $330.72 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $241.11 | 2019-2024 | Mounjaro |
| Astellas Pharma US INC | $179.95 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $88.44 | 2022-2023 | |
| Avanir Pharmaceuticals, INC. | $53.95 | 2022 | |
| Novo Nordisk INC | $34.01 | 2025 | Rybelsus, Ozempic |
| Otsuka America Pharmaceutical, INC. | $26.44 | 2025 | Rexulti |
| Abbvie INC. | $18.05 | 2022 | |
| Abbott Laboratories | $12.08 | 2021 | |
| Allergan, INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.